ArticleCancers2024

Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.

Christian Vaccarin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.